Potential cardioprotective effects of acetylcholinesterase inhibitors in patients with Alzheimer's disease

被引：0
|
作者：
Rampa, L. [1 ]
Gaspardone, C. [2 ]
Fiore, G. [1 ]
Romagnolo, D. [1 ]
Cerutti, A. [1 ]
Santangelo, R. [1 ]
Magnani, M. [1 ]
Piscazzi, G. [1 ]
Sgherzi, G. [1 ]
Filippi, M. [1 ]
Margonato, A. [1 ]
Fragasso, G. [1 ]
机构：
[1] Osped San Raffaele, Milan, Italy
[2] Osped San Raffaele, Cardiol, Milan, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Bertoletti, Erik
    Trabucchi, Marco
    Padovani, Alessandro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (03) : 220 - 223
  • [32] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini L.
    Chilovi B.V.
    Bertoletti E.
    Trabucchi M.
    Padovani A.
    Aging Clinical and Experimental Research, 2007, 19 (3) : 220 - 223
  • [33] Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
    Gajendra, Kumar
    Pratap, G. K.
    Poornima, D. V.
    Shantaram, Manjula
    Ranjita, G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 11
  • [34] Computational Prediction of Spiropyrazoline Derivatives as Potential Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment
    Alaouy, M. A. El
    Alaqarbeh, M.
    Bahi, S. El
    Boutalaka, M.
    Esslali, S.
    Sbai, A.
    Maghat, H.
    Guenoun, F.
    Choukrad, M.
    Lakhlifi, T.
    Bouachrine, M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2024, 50 (03) : 1016 - 1036
  • [35] Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
    Munoz-Torrero, D.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (24) : 2433 - 2455
  • [36] Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease
    Takatori, Yuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (08): : 607 - 616
  • [37] Discontinuation of acetylcholinesterase-inhibitors in Alzheimer's disease and its effects on cognitive functioning
    Steiger-Baechler, G
    Monsch, AU
    Bertoli, S
    Staehelin, HB
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S94 - S94
  • [38] Ligand-based discovery of new potential acetylcholinesterase inhibitors for Alzheimer's disease treatment
    Canizares-Carmenate, Y.
    Nam, N-H
    Diaz-Amador, R.
    Thuan, N. T.
    Dung, P. T. P.
    Torrens, F.
    Pham-The, H.
    Perez-Gimenez, F.
    Castillo-Garit, J. A.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2022, 33 (01) : 49 - 61
  • [39] FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease
    Paroni, Giulia
    Seripa, Davide
    Fontana, Andrea
    D'Onofrio, Grazia
    Gravina, Carolina
    Urbano, Maria
    Cascavilla, Leandro
    Pellegrini, Fabio
    Greco, Antonio
    Pilotto, Alberto
    CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 1783 - 1791
  • [40] Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease
    Melchiorre, C
    Andrisano, V
    Bolognesi, ML
    Budriesi, R
    Cavalli, A
    Cavrini, V
    Rosini, M
    Tumiatti, V
    Recanatini, M
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (22) : 4186 - 4189
12345